In other reports Stijnis et al. assessed for the JAK2-V617F mutation in different lymphocyte subsets of MPN patients with co-existing chronic lymphocytic leukemia (B-CLL). This evidence concerns the gene JAK2 and myeloproliferative neoplasm.